Table of Content
Table of Content
1 Radiopharmaceuticals in Nuclear Medicine Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Radiopharmaceuticals in Nuclear Medicine
1.3 Radiopharmaceuticals in Nuclear Medicine Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Radiopharmaceuticals in Nuclear Medicine
1.4.2 Applications of Radiopharmaceuticals in Nuclear Medicine
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Radiopharmaceuticals in Nuclear Medicine Industry Trends
1.5.2 Radiopharmaceuticals in Nuclear Medicine Drivers
1.5.3 Radiopharmaceuticals in Nuclear Medicine Market Challenges
1.5.4 Radiopharmaceuticals in Nuclear Medicine Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Radiopharmaceuticals in Nuclear Medicine Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Radiopharmaceuticals in Nuclear Medicine Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Radiopharmaceuticals in Nuclear Medicine
2.2.1 Major Players Manufacturing Base of Radiopharmaceuticals in Nuclear Medicine in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
2.3.3 Labor Cost of Radiopharmaceuticals in Nuclear Medicine
2.4 Market Channel Analysis of Radiopharmaceuticals in Nuclear Medicine
2.5 Major Down Stream Customers by Application
3 Global Radiopharmaceuticals in Nuclear Medicine Market, by Type
3.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2018-2021)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Production and Market Share by Type (2018-2021)
3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Diagnostic Nuclear Medicine
3.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Therapeutic Nuclear Medicine
3.3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate of Others
3.4 Global Radiopharmaceuticals in Nuclear Medicine Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Radiopharmaceuticals in Nuclear Medicine Market, by Application
4.1 Downstream Market Overview
4.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Application (2018-2021)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Hospitals (2018-2021)
4.3.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Specialty Clinics (2018-2021)
4.3.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Diagnostic Centers (2018-2021)
4.3.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2018-2021)
5 Global Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Region (2018-2021)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Region (2018-2021)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.4.2 North America Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.5 Europe Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.5.2 Europe Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.6 China Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.6.2 China Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.7 Japan Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.7.2 Japan Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.8.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.9 India Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.9.2 India Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.10 South America Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.10.2 South America Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.11 South Korea Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.11.2 South Korea Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
5.12 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Under COVID-19
5.12.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine SWOT Analysis
6 Global Radiopharmaceuticals in Nuclear Medicine Production by Top Regions (2018-2021)
6.1 Global Radiopharmaceuticals in Nuclear Medicine Production by Top Regions (2018-2021)
6.2 North America Radiopharmaceuticals in Nuclear Medicine Production and Growth Rate
6.3 Europe Radiopharmaceuticals in Nuclear Medicine Production and Growth Rate
6.4 China Radiopharmaceuticals in Nuclear Medicine Production and Growth Rate
6.5 Japan Radiopharmaceuticals in Nuclear Medicine Production and Growth Rate
6.6 India Radiopharmaceuticals in Nuclear Medicine Production and Growth Rate
7 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Regions (2018-2021)
7.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Regions (2018-2021)
7.2 North America Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.4 China Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.5 Japan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.6 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.7 India Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.8 South America Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.9 South Korea Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
7.10 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 Taiyo Nippon Sanso Corporation Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.2.3 Taiyo Nippon Sanso Corporation Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Nordion, Inc. Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.3.3 Nordion, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Institute Of Radioelement (IRE) Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.4.3 Institute Of Radioelement (IRE) Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Institute of Atomic Energy Polatom Radioisotope Centre Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.5.3 Institute of Atomic Energy Polatom Radioisotope Centre Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Fujifilm Holdings Corporation Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.6.3 Fujifilm Holdings Corporation Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Ntp Radioisotopes (Pty), Ltd. Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.7.3 Ntp Radioisotopes (Pty), Ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Board of Radiation And Isotope Technology (BRIT) Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.8.3 Board of Radiation And Isotope Technology (BRIT) Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Cardinal Health, Inc. Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.9.3 Cardinal Health, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 GE Healthcare (Subsidiary Of General Electric Company) Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.10.3 GE Healthcare (Subsidiary Of General Electric Company) Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Eczacibasi-Monrol Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.11.3 Eczacibasi-Monrol Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Bracco Imaging S.P.A. Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.12.3 Bracco Imaging S.P.A. Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Australian Nuclear Association And Technology Organization (ANSTO) Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.13.3 Australian Nuclear Association And Technology Organization (ANSTO) Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Institute of Isotopes Co., Ltd. Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.14.3 Institute of Isotopes Co., Ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Isotec, Inc. (Sigma-Aldrich) Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.15.3 Isotec, Inc. (Sigma-Aldrich) Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Lantheus Medical Imaging, Inc. Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.16.3 Lantheus Medical Imaging, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 IBA Group Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.17.3 IBA Group Sales, Revenue, Price, Gross Margin 2018-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 Rotem Industries, Ltd., Inc. Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.18.3 Rotem Industries, Ltd., Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Siemens Healthcare (Subsidiary Of Siemens AG) Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.19.3 Siemens Healthcare (Subsidiary Of Siemens AG) Sales, Revenue, Price, Gross Margin 2018-2021
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19
8.20 Urenco Limited Market Performance Analysis
8.20.1 Company Profiles
8.20.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.20.3 Urenco Limited Sales, Revenue, Price, Gross Margin 2018-2021
8.20.4 Company Recent Development
8.20.5 Strategies for Company to Deal with the Impact of COVID-19
8.21 Cambridge Isotope Laboratories, Inc. Market Performance Analysis
8.21.1 Company Profiles
8.21.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.21.3 Cambridge Isotope Laboratories, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.21.4 Company Recent Development
8.21.5 Strategies for Company to Deal with the Impact of COVID-19
8.22 Covidien, Plc Market Performance Analysis
8.22.1 Company Profiles
8.22.2 Radiopharmaceuticals in Nuclear Medicine Product Profiles, Application and Specification
8.22.3 Covidien, Plc Sales, Revenue, Price, Gross Margin 2018-2021
8.22.4 Company Recent Development
8.22.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Radiopharmaceuticals in Nuclear Medicine Market Analysis and Forecast by Type and Application
9.1 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Diagnostic Nuclear Medicine Market Revenue and Volume Forecast (2021-2026)
9.1.2 Therapeutic Nuclear Medicine Market Revenue and Volume Forecast (2021-2026)
9.1.3 Others Market Revenue and Volume Forecast (2021-2026)
9.2 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospitals Market Revenue and Volume Forecast (2021-2026)
9.2.2 Specialty Clinics Market Revenue and Volume Forecast (2021-2026)
9.2.3 Diagnostic Centers Market Revenue and Volume Forecast (2021-2026)
9.2.4 Others Market Revenue and Volume Forecast (2021-2026)
10 Radiopharmaceuticals in Nuclear Medicine Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Radiopharmaceuticals in Nuclear Medicine Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
